Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Debt / NOTE 7.500% 5/0
-
Number of holders
-
2
-
Total principal
-
75K
-
Principal change
-
-2M
-
Total reported value, excl. options
-
$610K
-
Value change
-
-$11.8M
-
Number of sells
-
-1
-
Price
-
$8.13
Significant Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 as of Q2 2017
2 filings reported holding 868459AB4 - SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 as of Q2 2017.
SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 has 2 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $75K of principal
.
Largest 3 bondholders include GOLDMAN SACHS GROUP INC ($50K of principal), WELLS FARGO & COMPANY/MN ($25K of principal), and 683 Capital Management, LLC ($0 of principal).
This table shows the top 2 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.